Skip to main content
. 2018 Aug 1;39(45):4020–4029. doi: 10.1093/eurheartj/ehy452

Table 3.

Aggregate patient characteristics

Cryoablation (Group 1) (n = 5608) PV isolation (Group 2) (n = 3167) LA ablation (Group 3) (n = 8336) LA + RA ablation (Group 4) (n = 2403) Any left atrial ablation procedure (Groups 1–4) (n = 19 514) Isolated right atrial ablation procedure (Group 5) (n = 13 871) P-value (1–4 vs. 5)
Age (years), mean ± SD 62.9 ± 10.7 62.7 ± 10.6 63.7 ± 10.8 63.8 ± 10.9 63.3 ± 10.8 67.2 ± 11.9 <0.001
 ≤50 years, n (%) 741 (13.2) 427 (13.5) 997 (12.0) 274 (11.4) 2439 (12.5) 1210 (8.7) <0.001
 51–60 years, n (%) 1382 (24.6) 816 (25.8) 1959 (23.5) 553 (23.0) 4710 (24.1) 2298 (16.6) <0.001
 61–70 years, n (%) 1906 (34.0) 1011 (31.9) 2686 (32.2) 773 (32.2) 6376 (32.7) 3870 (27.9) <0.001
 71–80 years, n (%) 1497 (26.7) 873 (27.6) 2540 (30.5) 760 (31.6) 5670 (29.1) 5226 (37.7) <0.001
 >80 years, n (%) 82 (1.5) 40 (1.3) 154 (1.8) 43 (1.8) 319 (1.6) 1267 (9.1) <0.001
Males, n (%) 3270 (58.3) 1941 (61.3) 5069 (60.8) 1483 (61.7) 11769 (60.3) 9964 (71.8) <0.001
Paroxysmal atrial fibrillation, n (%) 3893 (69.4) 1907 (60.2) 4428 (53.1) 1048 (43.6) 11276 (57.8) 3850 (27.8) <0.001
Persistent atrial fibrillation, n (%) 1755 (31.3) 1226 (38.7) 3508 (42.1) 1133 (47.1) 7622 (39.1) 1602 (11.5) <0.001
Permanent atrial fibrillation, n (%) 96 (1.7) 37 (1.2) 220 (2.6) 36 (1.5) 389 (2.0) 314 (2.3) 0.10
Atrial flutter, n (%) 312 (5.6) 324 (10.2) 1517 (18.2) 1200 (49.9) 3353 (17.2) 12333 (88.9) <0.001
Hypertension, n (%) 3484 (62.1) 2062 (65.1) 5230 (62.7) 1461 (60.8) 12238 (62.7) 8894 (64.1) 0.009
Chronic obstructive pulmonary disease, n (%) 152 (2.7) 94 (3.0) 279 (3.3) 53 (2.2) 578 (3.0) 990 (7.1) <0.001
Pulmonary hypertension, n (%) 105 (1.9) 91 (2.9) 252 (3.0) 74 (3.1) 522 (2.7) 517 (3.7) <0.001
Obstructive sleep apnoea, n (%) 184 (3.3) 111 (3.5) 285 (3.4) 78 (3.2) 658 (3.4) 496 (3.6) 0.32
Hyperthyroidism, n (%) 113 (2.0) 93 (2.9) 219 (2.6) 40 (1.7) 465 (2.4) 302 (2.2) 0.22
Diabetes mellitus, n (%) 562 (10.0) 348 (11.0) 973 (11.7) 259 (10.8) 2142 (11.0) 2754 (19.9) <0.001
Chronic kidney disease, n (%) 323 (5.8) 174 (5.5) 837 (10.0) 193 (8.0) 1527 (7.8) 2066 (14.9) <0.001
Coronary artery disease, n (%) 1108 (19.8) 666 (21.0) 182 (2.2) 446 (18.6) 4041 (20.7) 4452 (32.1) <0.001
Dilative cardiomyopathy, n (%) 146 (2.6) 148 (4.7) 402 (4.8) 132 (5.5) 828 (4.2) 829 (6.0) <0.001
Heart failure, n (%) 642 (11.4) 395 (12.5) 1418 (17) 455 (18.9) 2910 (14.9) 3470 (25.0) <0.001
Aortic stenosis, n (%) 88 (1.6) 82 (2.6) 177 (2.1) 51 (2.1) 398 (2.0) 440 (3.2) <0.001
Mitral valve disease, n (%) 313 (5.6) 172 (5.4) 549 (6.6) 142 (5.9) 1176 (6.0) 936 (6.7) 0.008
Peripheral artery disease, n (%) 55 (1.0) 43 (1.4) 82 (1.0) 20 (0.8) 200 (1.0) 408 (2.9) <0.001
Duration of hospital stay (days), mean ± SD 4.2 ± 3.7 4.1 ± 3.7 4.7 ± 4.4 4.6 ± 4.3 4.4 ± 4.1 5.1 ± 6.7 <0.001

Statistical comparisons are calculated for two columns on the right-hand side. Among them, the left column includes any left atrial ablation procedure using any source of energy, the right column includes isolated right atrial ablation procedures using any source of energy. Comparisons using Fisher’s exact test or Student’s t-test as appropriate.